GFI1 and acute myeloid leukemia: In order to obtain a cross-entity assessment that is not only focused on AML and to obtain an initial overview of the effects of the polymorphism, we addressed this question in the human myeloid leukemia cell line K562, in which we knocked in a GFI1-36N variant.